Goldman Sachs Group Inc Dexcom Inc Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Dexcom Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,619,676 shares of DXCM stock, worth $232 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,619,676
Previous 2,263,098
15.76%
Holding current value
$232 Million
Previous $152 Million
34.32%
% of portfolio
0.03%
Previous 0.03%
Shares
20 transactions
Others Institutions Holding DXCM
# of Institutions
1,085Shares Held
352MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4.11 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.05 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.47 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.29 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.27 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...